Acute pancreatitis and diabetic keto-acidosis in accidental hypothermia and hypothermic myxoedema.
Introduction
The development of neoplasms after immunosuppressive therapy has been reported previously (Doll and Kinlen, 1970) . The great majority have been either of the lymphoreticular type, frequently involving the central nervous system, or cancers involving superficial epithelium. The occurrence of a poorly differentiated sarcoma in a patient during treatment with cyclophosphamide is reported.
Case history
The patient, a janitor aged 62, initially presented in August 1969 with painful hands and feet. A diagnosis of seropositive rheumatoid arthritis was made and treated with chloroquine phosphate 250 mg daily for 1 year. In November 1972 there was an exacerbation of his joint symptoms and he was started on prednisolone 15 mg daily but continuing disease activity necessitated the addition of cyclophosphamide 50 mg twice daily in February 1975.
In August 1975 he was admitted to the Manchester Royal Infirmary. There was a 2-month history of progressive exertional dyspnoea and 10 kg weightloss. Examination revealed a hypercorticoid cyanosed patient with finger clubbing, a left pleural effusion and chronic rheumatoid joint changes. Investigations showed a haemoglobin of 13-6 g/100 ml; white cell count of 6,900 with a normal differential; an ESR of 40 mm in 1 hr (Westergren). Routine biochemical tests were all normal. A chest X-ray film confirmed the presence of a left pleural effusion. Cytological examination of the blood-stained pleural aspirate showed it to contain neoplastic cells and needle biopsy of the pleura revealed infiltration with anaplastic tumour cells.
The patient's clinical condition deteriorated and he died 1 week later. At post-mortem the pleura was covered with a grey nodular tumour but sections of the bronchi failed to reveal any primary tumour. Histological examination of the tumour confirmed it to be a poorly differentiated sarcoma.
Discussion
The alkylating agent cyclophosphamide appears to be an effective therapeutic agent in certain connective tissue disorders including rheumatoid arthritis (Cooperating Clinics Committee, 1970 
Introduction
Histiocytic medullary reticulosis (HMR) is a rare disorder with a rapidly progressive course, characterized by wasting, fever and enlargement of liver and spleen. The essential anatomical change is a proliferation of atypical histiocytic cells, mainly in the spleen, liver, lymph nodes and bone marrow and was first reported by Scott and Robb Smith (1939).
Case report
A 45-year-old man was referred to the East Birmingham Hospital with rigors and severe sore throat of 1 week's duration. He had suffered from depression for 4 months and had been under treatment for the last month with tranylcypromine (parnate), a monoamine oxidase inhibitor. He was of good general physique, the skin showed patches of seborrhoeic eczema but no bruising or petechial haemorrhage. There were deep ulcers covered with a grey exudate on the fauces and the spleen was firm and just palpable. He had a swinging pyrexia of up to 40°C.
The haemoglobin level fell from 12-3 g/dl on admission to 7-9 g/dl by the ninth day. There was evidence of extensive haemolysis with a four-fold rise in unconjugated bilirubin and an excess of urobilinogen in the urine. Liver enzymes were moderately elevated. An initial peripheral white blood
